Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
Lancet Child Adolesc Health
; 6(3): 171-184, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-35123664
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arachis
/
Allergens
/
Desensitization, Immunologic
/
Probiotics
/
Peanut Hypersensitivity
/
Lacticaseibacillus rhamnosus
/
Immunologic Factors
Type of study:
Clinical_trials
Limits:
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Country/Region as subject:
Oceania
Language:
En
Journal:
Lancet Child Adolesc Health
Year:
2022
Type:
Article
Affiliation country:
Australia